Revenue: The sum of all revenue fields included for a company's operating activities.
Neurocrine Biosciences, Inc. (NBIX) had Revenue of $572.60M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$572.60M |
$7.90M |
|
$9.20M |
|
$563.40M |
|
$549.00M |
|
$23.60M |
|
$-8.90M |
|
$14.70M |
|
$45.30M |
|
$7.90M |
|
$7.90M |
|
$7.90M |
|
$52.66M |
|
$23.60M |
|
$31.20M |
|
99.70M |
|
102.50M |
|
$0.08 |
|
$0.08 |
|
| Balance Sheet Financials | |
$1.64B |
|
$87.00M |
|
$2.05B |
|
$3.69B |
|
$522.90M |
|
-- |
|
$629.10M |
|
$1.15B |
|
$2.54B |
|
$2.50B |
|
$2.54B |
|
99.00M |
|
| Cash Flow Statement Financials | |
$64.80M |
|
$14.20M |
|
$-117.90M |
|
$241.00M |
|
$202.10M |
|
$-38.90M |
|
$52.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
98.39% |
|
4.12% |
|
4.12% |
|
-- |
|
2.57% |
|
1.38% |
|
$54.10M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.16 |
|
1.11 |
|
81.10 |
|
0.31% |
|
0.32% |
|
0.21% |
|
0.31% |
|
$25.61 |
|
$0.53 |
|
$0.63 |
|